Quantcast
Last updated on April 17, 2014 at 8:20 EDT

Latest Morphine Stories

2012-07-09 14:23:16

STAMFORD, Conn., July 9, 2012 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) is requiring opioid analgesic companies to implement a new, shared Risk Evaluation & Mitigation Strategy (REMS) for all extended-release and long-acting opioid pain medications to ensure that the benefits continue to outweigh the risks of adverse outcomes (addiction, unintentional overdose, and death) resulting from inappropriate prescribing, abuse, and misuse. The principal components of this REMS...

Pharma Begins OxyContin Trials In Children
2012-07-04 10:32:47

Lawrence LeBlond for redOrbit.com - Your Universe Online Purdue Pharma, the maker of the widely-used, and equally-abused drug, OxyContin, is now looking to gain 6 extra months of patent protection with new clinical trials that could possibly see market of the drug to children. The patent on the potent painkiller is set to expire in 2013 and Purdue, following in the footsteps of other drugmakers that have pursued pediatric-exclusivity, is testing the drug´s potential for use in...

2012-06-20 14:17:21

Genetics play a significant role in determining which patients will suffer the most from the disturbing side effects of opiates, commonly prescribed painkillers for severe to moderate pain, according to a new Stanford University School of Medicine study, which pinpoints nausea, slowed breathing and potential for addiction as heritable traits. "One of the most hated side effects of these opiates, nausea, is strongly inherited," said Martin Angst, MD, professor of anesthesia and one of two...

2012-06-15 23:00:41

Normally used in clinical settings, Puridone has been recently released to the general public online as a 60-day "in home" treatment to help those dealing with opiate dependency and painkiller addiction. In clinical studies conducted in 2012, Puridone demonstrated a remarkable increase in energy, sleep and sex drive, while simultaneously lowering withdrawal symptoms, anxiety and depression scores. Jamison, PA (PRWEB) June 15, 2012 The Puridone Program is an incredible new proprietary...

2012-06-14 23:01:57

The Discovery of the Opiate Cure by Dr. Robert Cochran, Jr. Could Be a New Hope for Sufferers of Certain Psychiatric Diseases Nashville, TN (PRWEB) June 15, 2012 Doctor Robert T. Cochran, Jr. proposes what could be considered a controversial idea in medical circles. In The Opiate Cure, he asserts that certain types of psychiatric illnesses, collectively classified as the Bipolar Spectrum, are manageable, or even totally curable with the carefully measured administration of opiates. Opiates...

2012-06-11 23:02:57

Narconon Riverbend recently completed a survey which found that the overwhelming majority of addicts that attend its program lived in drug-free households at the time they began abusing drugs. Denham Springs, LA (PRWEB) June 11, 2012 Psychologists and mental health professionals are often at odds over the “nature vs. nurture” debate when it comes to the question of drug addiction. On the one side stand those who believe that a genetic predisposition toward addiction exists,...

2012-06-11 11:35:35

French researchers have found a way to identify quickly the 5-10% of patients in whom the commonly used painkiller, tramadol, does not work effectively. A simple blood test can produce a result within a few hours, enabling doctors to switch a non-responding patient on to another painkiller, such as morphine, which will be able to work in these patients. Dr Laurent Varin, an anesthesiologist at the Caen Teaching Hospital (Caen, France), presented the findings to the European Anaesthesiology...

2012-06-11 02:25:11

SHELTON, Conn., June 11, 2012 /PRNewswire/ -- Cara Therapeutics, Inc. today announced positive results from a Phase II study for the treatment of acute post-operative pain with its novel, peptide-based, peripherally-acting kappa opioid agonist, CR845. The study successfully met its primary endpoint which measured the effect of CR845 treatment on reducing the amount of rescue opioid analgesics used in the 24 hour period post-surgery, as well as secondary endpoints which...

2012-06-04 02:26:27

LOS ANGELES, June 4, 2012 /PRNewswire/ -- Chronic aches and pains can stem from a variety of sources, whether it's a car accident or other injury, an invasive medical procedure, the onset of arthritis or other diseases, or even an entirely unknown cause. In the fight to retain a comfortable lifestyle and remain mobile, many people find themselves struggling through courses of drugs and difficult physical therapy sessions - only to realize little to no improvement. When traditional therapies...

2012-05-23 02:26:47

SYDNEY and BEDMINSTER, N.J., May 23, 2012 /PRNewswire/ -- QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the United States Patent and Trademark Office (USPTO) issued the Company U.S. Patent No. 8,182,837, which does not expire until 2023. This patent covers a method of treatment of pain comprising the administration of the oral Dual Opioid®( )compositions of MoxDuo IR (Immediate Release) for the treatment of acute pain as well as MoxDuo CR (Controlled Release) for the...